Wolverine Asset Management LLC Uni Qure N.V. Call Options Transaction History

Wolverine Asset Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $5.62 Million - $11 Million	-142,700 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $7.43 Million - $11.6 Million	140,800 Added 7410.53%	142,700 $11.2 Million
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $52,041 - $129,979	1,900 New	1,900 $113,000

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $290M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.